Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - morphine sulfate pentahydrate 10mg - modified release tablet - 10 mg - active: morphine sulfate pentahydrate 10mg excipient: cetostearyl alcohol hyetellose lactose monohydrate magnesium stearate opadry tan 85f270017 purified talc water - indicated for the prolonged relief of opioid responsive severe and intractable pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - morphine sulfate pentahydrate 200mg (as pentahydrate, equiv to 150mg morphine base) - modified release tablet - 200 mg - active: morphine sulfate pentahydrate 200mg (as pentahydrate, equiv to 150mg morphine base) excipient: cetostearyl alcohol hyetellose macrogol 400 magnesium stearate opadry green purified talc purified water   - indicated for the prolonged relief of opioid responsive severe and intractable pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - morphine sulfate pentahydrate 30mg - modified release tablet - 30 mg - active: morphine sulfate pentahydrate 30mg excipient: cetostearyl alcohol hyetellose lactose monohydrate magnesium stearate opadry violet 0y-6708 purified talc purified water water - indicated for the prolonged relief of opioid responsive severe and intractable pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - morphine sulfate pentahydrate 60mg - modified release tablet - 60 mg - active: morphine sulfate pentahydrate 60mg excipient: cetostearyl alcohol hyetellose lactose monohydrate magnesium stearate opadry orange oy-3508 purified talc purified water water - indicated for the prolonged relief of opioid responsive severe and intractable pain.

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 10mg - modified release tablet - 10 mg - active: oxycodone hydrochloride 10mg excipient: magnesium stearate opadry white y-5r-18024-a polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 15mg - modified release tablet - 15 mg - active: oxycodone hydrochloride 15mg excipient: magnesium stearate opadry grey 05b97512 polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 20mg - modified release tablet - 20 mg - active: oxycodone hydrochloride 20mg excipient: magnesium stearate opadry pink ys-1r-14518-a polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 30mg - modified release tablet - 30 mg - active: oxycodone hydrochloride 30mg excipient: magnesium stearate opadry brown ys-1-16518-a polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 40mg - modified release tablet - 40 mg - active: oxycodone hydrochloride 40mg excipient: magnesium stearate opadry yellow ys-1r-12525-a polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 60mg - modified release tablet - 60 mg - active: oxycodone hydrochloride 60mg excipient: magnesium stearate opadry red 15b25501 polyethylene oxide - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia